Syndecan 1 is a therapeutic target for KRAS-driven pancreatic cancer

被引：0
|
作者：
Takeda, Mitsunobu
Yang, Zecheng
Theardy, Madeline S.
Sorokin, Alexey
Coker, Oluwadara
Chen, Shuaitong
Vien, Long T.
Bover, Laura
Ying, Haoqiang
Kopetz, Scott
Yao, Wantong
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PANCREATIC24-IA-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA-08
引用
收藏
页数：3
相关论文
共 50 条
  • [31] THE ROLE OF PRRX1 IN REGULATING KRAS-DRIVEN PANCREATIC ACINAR TO DUCTAL METAPLASIA
    Li, Alina L.
    Sugiura, Kensuke
    Suzuki, Kensuke
    Pitarresi, Jason R.
    Chiarella, Anna
    Efe, Gizem
    Chandwani, Rohit
    Rustgi, Anil
    GASTROENTEROLOGY, 2022, 162 (07) : S912 - S912
  • [32] A one-two punch for KRAS-driven cancer
    Megan Cully
    Nature Reviews Drug Discovery, 2015, 14 : 600 - 600
  • [33] Snail Bypasses Senescence and Accelerates Tumor Progression in a Kras-driven Mouse Model of Pancreatic Cancer
    Paul, M. C.
    Walter, B. M.
    Seidler, B.
    Schnieke, A.
    Schmid, R. M.
    Schneider, G.
    Saur, D.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S168 - S169
  • [34] Unfolding the role of cell state on stress granule heterogeneity and function in KRAS-driven pancreatic cancer
    Redding, Alexandra
    Fonteneau, Guillaume
    Grabocka, Elda
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [35] Virally enhanced p53 reactivation impairs KRAS-driven pancreatic cancer invasion
    Koujima, Takeshi
    Tazawa, Hiroshi
    Leda, Takeshi
    Kuwada, Kazuya
    Tanimoto, Terutaka
    Kuroda, Shinji
    Kishimoto, Hiroyuki
    Nishizaki, Masahiko
    Urata, Yasuo
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2016, 76
  • [36] Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor Growth
    Nagdas, Sarbajeet
    Kashatus, Jennifer A.
    Nascimento, Aldo
    Hussain, Syed S.
    Trainor, Riley E.
    Pollock, Sarah R.
    Adair, Sara J.
    Michaels, Alex D.
    Sesaki, Hiromi
    Stelow, Edward B.
    Bauer, Todd W.
    Kashatus, David F.
    CELL REPORTS, 2019, 28 (07): : 1845 - +
  • [37] Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
    Moiez Ali
    Erin Kaltenbrun
    Gray R. Anderson
    Sarah Jo Stephens
    Sabrina Arena
    Alberto Bardelli
    Christopher M. Counter
    Kris C. Wood
    Nature Communications, 8
  • [38] Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
    Ali, Moiez
    Kaltenbrun, Erin
    Anderson, Grace R.
    Stephens, Sarah Jo
    Arena, Sabrina
    Bardelli, Alberto
    Counter, Christopher M.
    Wood, Kris C.
    NATURE COMMUNICATIONS, 2017, 8
  • [39] Kras-Driven Autophagy Protects Pancreatic Cancer Cells From Death During Hypoxia and Nutrient Deprivation
    Maertin, Sandrina
    Nitsche, Claudia J.
    Moore, Ryan M.
    Elperin, Jason M.
    Sendler, Matthias
    Grippo, Paul
    Eibl, Guido
    Mayerle, Julia
    Lerch, Markus M.
    Gukovskaya, Anna S.
    GASTROENTEROLOGY, 2014, 146 (05) : S870 - S870
  • [40] MRTX0902: A SOS1 inhibitor for therapeutic intervention of KRAS-driven cancers
    Ketcham, John M.
    Khare, Shilpi
    Sudhakar, Niranjan
    Briere, David M.
    Yan, Larry
    laguer, JaDe
    Vegar, Laura
    Vanderpool, Darin
    Hallin, Jill
    Hargis, Lauren
    Bowcut, Vickie
    Lawson, David
    Gunn, Robin J.
    Ivetac, Anthony
    Thomas, Nicole C.
    Saechao, Barbara
    Nguyen, Natalie
    Clarine, Jeffrey
    Rahbaek, Lisa
    Smith, Christopher R.
    Burns, Aaron C.
    Marx, Matthew A.
    Christensen, James G.
    Olson, Peter
    Haling, Jacob R.
    CANCER RESEARCH, 2022, 82 (12)
12345